ICU Medical, Inc. (ICUI)
NASDAQ: ICUI · Real-Time Price · USD
141.97
-0.25 (-0.18%)
Mar 7, 2025, 4:00 PM EST - Market closed
ICU Medical Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for ICU Medical stock have an average target of 199.67, with a low estimate of 190 and a high estimate of 209. The average target predicts an increase of 40.64% from the current stock price of 141.97.
Analyst Consensus: Buy
* Price targets were last updated on Dec 11, 2024.
Analyst Ratings
The average analyst rating for ICU Medical stock from 4 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 2 | 2 | 2 | 1 |
| Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 5 | 4 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Jefferies | Jefferies | Hold → Strong Buy Upgrades $200 | Hold → Strong Buy | Upgrades | $200 | +40.87% | Dec 11, 2024 |
| Keybanc | Keybanc | Buy Maintains $198 → $209 | Buy | Maintains | $198 → $209 | +47.21% | Nov 13, 2024 |
| Needham | Needham | Hold Reiterates n/a | Hold | Reiterates | n/a | n/a | Nov 13, 2024 |
| Keybanc | Keybanc | Buy Maintains $147 → $198 | Buy | Maintains | $147 → $198 | +39.47% | Oct 15, 2024 |
| Jefferies | Jefferies | Hold Initiates $183 | Hold | Initiates | $183 | +28.90% | Oct 14, 2024 |
Financial Forecast
Revenue This Year
2.37B
from 2.38B
Decreased by -0.67%
Revenue Next Year
2.44B
from 2.37B
Increased by 3.00%
EPS This Year
7.27
from -4.83
EPS Next Year
8.71
from 7.27
Increased by 19.78%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 2.5B | 2.7B | 2.4B | |
| Avg | 2.4B | 2.4B | 2.3B | |
| Low | 2.0B | 2.1B | 2.2B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 7.0% | 12.6% | -1.8% | |
| Avg | -0.7% | 3.0% | -4.6% | |
| Low | -14.7% | -10.5% | -8.3% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | 7.83 | 9.38 | 11.06 | |
| Avg | 7.27 | 8.71 | 10.74 | |
| Low | 6.53 | 8.03 | 10.32 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|
| High | - | 28.9% | 26.9% | |
| Avg | - | 19.8% | 23.3% | |
| Low | - | 10.4% | 18.5% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.